Hofseth BioCare ASA

HBC

NO0010598683

Food Processing

Market Closed - Oslo Bors Other stock markets 08:15:00 28/05/2024 pm IST			5-day change	1st Jan Change
2.1 ^NOK	-2.33%		-2.33%	-19.85%

14/03	Hofseth BioCare ASA Announces Board Changes	CI
09/02	Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Hofseth Biocare Asa Reports Earnings Results for the First Quarter Ended March 31, 2021

May 21, 2021 at 01:38 pm IST

Hofseth BioCare ASA announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was NOK 16.835 million compared to NOK 18.524 million a year ago. Operating loss was NOK 25.033 million compared to NOK 15.989 million a year ago. Net loss was NOK 26.844 million compared to NOK 17.885 million a year ago. Basic loss per share from continuing operations was NOK 0.08 compared to NOK 0.05 a year ago.

Latest news about Hofseth BioCare ASA

Hofseth BioCare ASA Announces Board Changes	14/03	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	09/02	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/23/25	CI
Hofseth BioCare Secures Seed Funding for Pre-clinical Study of Prostate Cancer Treatment	17/23/17	MT
Aqua Bio Technology Asa Announces Distribution Agreement with Hofseth Biocare Asa	12/23/12	CI
Hofseth Biocare ASA Announces the Online Publication of Its Abstract	30/23/30	CI
Norway’s Hofseth Biocare Moves Prostate Cancer Co-treatment Project to US Entity	15/23/15	MT
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt	31/23/31	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	10/23/10	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Hofseth BioCare Says Preclinical Trial Shows ProGo Peptides Support Gut Health	17/22/17	MT
Hofseth BioCare ASA's Progo Bioactive Peptides Now Is A "New Dietary Ingredient" for the US FDA	29/22/29	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/22/26	CI
Hofseth Biocare Appoints CFO as CEO	29/22/29	MT
Hofseth BioCare ASA Announces Executive Changes	29/22/29	CI
Hofseth BioCare ASA announced that it has received NOK 1.4196 billion in funding	01/22/01	CI
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2022	06/22/06	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	04/22/04	CI
Hofseth BioCare ASA Approves Election Amy Novogratz to Its Board of Directors	03/21/03	CI
Hofseth Biocare Gets US Dietary Ingredient Status for Nutritional Suplements Extracted from Salmon	02/21/02	MT
Hofseth Biocare ASA Successfully Receive New Dietary Ingredient Status from the US FDA	02/21/02	CI

Chart Hofseth BioCare ASA

Duration

Period

More charts

Company Profile

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Sector

Food Processing

Calendar

30/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
HOFSETH BIOCARE ASA	-19.85%	79.17M
NESTLÉ S.A.	-6.02%	264B
MONDELEZ INTERNATIONAL, INC.	-6.71%	90.64B
KRAFT HEINZ	-5.22%	42.56B
DANONE	+0.17%	41.13B
THE HERSHEY COMPANY	+5.99%	39.96B
GENERAL MILLS, INC.	+2.36%	37.64B
ARCHER-DANIELS-MIDLAND COMPANY	-15.69%	30.11B
NESTLÉ INDIA LIMITED	-6.94%	28.41B
ASSOCIATED BRITISH FOODS PLC	+11.58%	25.17B